一、基本情況
鄭治,醫學博士;校聘教授,碩士生導師。主要從事心血管疾病機制探索及仿生藥物遞送載體研究。先後承擔國家自然科學基金青年項目、中國博士後面上基金、湖南省自然科學基金青年項目等課題5項。以第一作者或通訊在J. Control. Release, Chem. Eng. J, Adv Healthc Mater等領域内雜志發表論文14篇,授權專利2項。
Email: zhengzhi@usc.edu.cn, 137959828@qq.com
二、研究領域
1.仿生藥物遞送系統:主要進行可注射水凝膠作為藥物載體系統用于心肌梗死和骨修複的研究。
2. 心血管疾病的發病機制研究:動脈粥樣硬化和心肌梗死的病理分子機制和防治的研究。
三、工作及學習經曆
2024/9-至今,南華大學,2003网站太阳集团,講師
2022/10-2024/9,2003网站太阳集团,衡陽醫學院,博士後
2019/9-2022/6,南華大學,衡陽醫學院,博士
四、社會兼職
中國抗癌協會委員
五、教學工作
目前承擔課程:藥劑學、藥用高分子材料學、藥學前沿研讨等。
六、承擔課題
1. 國家自然科學基金,載miR-199a-3p的抗氧化膠束-水凝膠複合體系構建及其重啟心梗後心肌再生研究(82304429),2024.1-2026.12
2. 中國博士後面上項目,次序響應載OI抗氧化水凝膠構建及其重塑心髒能量代謝促進心肌修複的研究(2024M751350),2024.1-2025.12
3. 湖南省自然科學基金,基于序貫誘導軟骨再生的仿生雙交聯水凝膠的構築及其作用機制研究(2023JJ40570),2023.1-2025.12
4. 2003网站太阳集团博士後科研啟動基金,基于神經酰胺酶多肽水凝膠通過抑制心肌氧化應激促進梗死後心肌修複(220XQD106),2022.1-2025.12
七、代表性文章
1) Zheng, Z, Sun, J, Wang, J, He, S, Liu, Z, Xie, J, Yu, C. Y. *, & Wei, H*. Enhancing myocardial infarction treatment through bionic hydrogel-mediated spatial combination therapy via mtDNA-STING crosstalk modulation. J. Control. Release, 2024, 371, 570–587.
2) Zheng Z, Sun Jian, Wang Jun, He Suisui, Huang Yun, Yang Xu, Zhao Yuqi, Yu Cui-Yun*, Wei Hua*. A negative feedback bionic hydrogel reverses damaged cartilage microenvironment and induces targeted BMSCs differentiation for cartilage regeneration. Chemical Engineering Journal. 2023, Volume 473, 145228.
3) Zheng Z, Guo Z, Zhong F, Wang B, Liu L, Ma W, Yu CY*, Wei H*. A dual crosslinked hydrogel-mediated integrated peptides and BMSC therapy for myocardial regeneration. J. Control. Release. 2022, 7;347:127-142.
4) Zheng Z, Lei C, Liu H, Jiang M, Zhou Z, Zhao Y, Yu CY, Wei H. A ROS-Responsive Liposomal Composite Hydrogel Integrating Improved Mitochondrial Function and Pro-Angiogenesis for Efficient Treatment of Myocardial Infarction. Advanced Healthcare Materials. 2022;11(19):e2200990.
5) Zheng Z, Tan Y, Li Y, Liu Y, Yi G, Yu CY*, Wei H*. Biotherapeutic-loaded injectable hydrogels as a synergistic strategy to support myocardial repair after myocardial infarction. J. Control. Release. 2021, 10;335:216-236.
6) Zheng Z, Yu C*, Wei H*. Injectable Hydrogels as Three-Dimensional Network Reservoirs for Osteoporosis Treatment. Tissue Eng Part B Rev. 2021 Oct;27(5):430-454.
7) Yuqi Zhao1, Zhi Zheng1*, Cui-Yun Yu*, and Hua Wei*. Engineered cyclodextrin-based supramolecular hydrogels for biomedical applications. J Mater Chem. B. 2023 Dec 22;12(1):39-63.
8) Tan, Y, Nie, Y, ZhengWen, L, and Zheng, Z*. Comparative effectiveness of myocardial patches and intramyocardial injections in treating myocardial infarction with a MitoQ/hydrogel system. J Mater Chem. B, 2024 Jun 19;12(24):5838-5847.
9)Zhenqiu Liu1, Zhi Zheng1*, Jiahao Xie, Hua Wei*, and Cui-Yun Yu* Hydrogel-based Cardiac Patches for Myocardial Infarction Therapy: Recent Advances and Challenges. Materials Today bio. 2024,(接受)
地址:中國 湖南衡陽 常勝西路28号 聯系方式:0734-8282914 郵編:421001 版權所有:2003网站太阳集团-首页(欢迎您)